Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
General Motors Company ( GM - Analyst Report ) is planning to invest $1 billion in its production units in Russia over the next five years, according to Reuters. This initiative will increase production of cars and components in one of the fastest-growing auto markets in the world.
The company makes cars in its Kaliningrad, St. Petersburg and Togliatti plants in Russia. The investment is aimed at boosting output capacity and sourcing local components. The St. Petersburg plant, which manufactures the Chevrolet Cruze sedan and the Opel Astra hatchback, will be also producing Astra sedan following the expansion.
General Motors also plans to increase the production of Chevrolet Niva sport utility vehicle, which is being manufactured through its joint venture with Russia's AvtoVaz. This would escalate the Chevy Niva production to 120,000 units from 70,000 units. With this, the company will be producing 350,000 vehicles in Russia annually.
Last year, car sales in Russia went up 40% to 2.5 million units. Although growth has decelerated this year, General Motors, which is the second largest car-selling company in Russia, anticipates further growth in production. The company plans to increase production to 230,000 vehicles per year in its St. Petersburg plant.
General Motors, in the second quarter of 2012, registered a 41% decline in its profit to $1.49 billion or 90 cents per share from $2.52 billion or $1.54 in the corresponding quarter of 2011. Nevertheless, earnings per share exceeded the Zacks Consensus Estimate by 15 cents.
Total revenues fell 4.5% year over year to $37.60 billion in the quarter, missing the Zacks Consensus Estimate of $37.98 billion. The declines in the profit and revenues were attributable to the strengthening of the U.S. dollar against most of the major currencies as well as weak macroeconomic conditions globally, especially in Europe and South America.
Like its competitor Ford Motor Co. ( F - Analyst Report ) , the company's significant exposure to troubled Europe has adversely affected its operations in the continent. Currently, General Motors retains a Zacks #3 Rank, which translates into a short-term Hold rating.
Read the full reports :
Analyst Report on GM
Analyst Report on F